Not finding it? Sign in to also search OpenAlex live.
-
Indirect Treatment Comparisons of Daratumumab, Pomalidomide, and Dexamethasone Versus Daratumumab, Bortezomib, and Dexamethasone or Bortezomib and Dexamethasone in Patients with Difficult-to-Treat Relapsed/Refractory Multiple Myeloma
Jianming He, Heather Berringer, Bart M. S. Heeg, Tobias Kampfenkel, João Mendes, Annette Lam, +1 more
1citations
1 result